GLP-1 conversations typically focus on weight, blood sugar, and hearts. Joints, a topic very close to my heart, or, um, knees, barely come up. But at ACR Convergence 2026, the … Continue readingBattling Barking Joints? GLP-1s Join the Conversation
Mounjaro just crossed a threshold no other GIP/GLP-1 medication has crossed before. The FDA has approved it specifically to reduce the risk of major cardiovascular events, heart attack, stroke, and … Continue readingGLP-1 Mounjaro Crosses a New Threshold
I want to be upfront about where I’m coming from. I believe firmly in healthcare freedom, in people having real agency over their own bodies and treatment decisions. I don’t … Continue readingWhat’s Actually in That Retatrutide Vial?
It’s one of those things that feels obvious when you’re the one living it. Manage a chronic disease well, and you need less emergency care down the road. Obesity is … Continue readingThe “No Proof” GLP-1 Insurance Excuse Just Got Weaker
Within the first few days of starting tirzepatide, I felt something shift that had nothing to do with the scale. I have psoriatic arthritis and osteoarthritis, and for years, inflammation … Continue readingThe GLP-1 Inflammation Drop That Led Me to Drop My Cane
Full disclosure before we get into this one: I’m a shots-for-life girlie. I don’t have plans to switch off my injectable anytime soon. But I also know I’m not the … Continue readingWhat Happens When You Stop the GLP-1 Shots [STUDY]
Some research findings feel obvious the moment you read the headline. Combining a GLP-1 with exercise works better than either one alone? Of course it does. But “obvious” and “actually … Continue readingWhat the Data Says About Stacking GLP-1s and Exercise
If you’ve spent any time in GLP-1 forums or comment sections, you’ve run into the warning, usually delivered with total confidence. “You’ll gain it all back.” The idea that massive … Continue readingThe GLP-1 Regain Myth, Debunked By Data
123%. That’s how much higher the risk of death was for people over 50 who had both abdominal obesity and vitamin D deficiency, compared to people with neither. A new … Continue readingThe Feedback Loop That Doubles Your Death Risk
For years, the tirzepatide-versus-semaglutide debate has been fought with one hand tied behind everyone’s back. Both drugs had impressive trial results, but no study had ever put them head-to-head in … Continue readingTirzepatide vs. Semaglutide: We Finally Have Head-to-Head GLP-1 Data
We tend to think of aging as something that occurs on a linear, set timeline. Birthdays pass, gray hair shows up, joints get creakier, and there’s not much to do … Continue readingIs Obesity Secretly Aging You Faster?